메뉴 건너뛰기




Volumn 41, Issue 1, 2010, Pages 96-106

Drug penetration model of vinblastine-treated Caco-2 cultures

Author keywords

Absorption; Caco 2; P glycoprotein; Permeability; VB Caco 2; Vinblastine

Indexed keywords

ALPRENOLOL; ATENOLOL; CAFFEINE; CALCEIN; CHLOROTHIAZIDE; CIMETIDINE; CORTICOSTERONE; CYCLOSPORIN A; CYTOCHROME P450; DEXAMETHASONE; DOXORUBICIN; FLUORESCEIN SODIUM; FUROSEMIDE; GLYCOPROTEIN P; IBUPROFEN; KETOCONAZOLE; LABETALOL; LAMOTRIGINE; LOPERAMIDE; LUCIFER YELLOW; PARACETAMOL; PHENAZONE; QUINIDINE; RANITIDINE; SALAZOSULFAPYRIDINE; TERFENADINE; TESTOSTERONE; VERAPAMIL; VINBLASTINE; WARFARIN; ANTINEOPLASTIC AGENT; MESSENGER RNA; MULTIDRUG RESISTANCE PROTEIN;

EID: 77954762783     PISSN: 09280987     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejps.2010.05.015     Document Type: Article
Times cited : (42)

References (57)
  • 2
    • 0035286778 scopus 로고    scopus 로고
    • Caco-2 monolayers in experimental and theoretical predictions of drug transport
    • Artursson P., Palm K., Luthman K. Caco-2 monolayers in experimental and theoretical predictions of drug transport. Adv. Drug Deliv. Rev. 2001, 46:27-43.
    • (2001) Adv. Drug Deliv. Rev. , vol.46 , pp. 27-43
    • Artursson, P.1    Palm, K.2    Luthman, K.3
  • 3
    • 0034821939 scopus 로고    scopus 로고
    • Role of transport proteins in drug absorption, distribution and excretion
    • Ayrton A., Morgan P. Role of transport proteins in drug absorption, distribution and excretion. Xenobiotica 2001, 31:469-497.
    • (2001) Xenobiotica , vol.31 , pp. 469-497
    • Ayrton, A.1    Morgan, P.2
  • 4
    • 14644398632 scopus 로고    scopus 로고
    • Cell culture-based models for intestinal permeability: a critique
    • Balimane P.V., Chong S. Cell culture-based models for intestinal permeability: a critique. Drug Disc. Today 2005, 10:335-343.
    • (2005) Drug Disc. Today , vol.10 , pp. 335-343
    • Balimane, P.V.1    Chong, S.2
  • 5
    • 33646640645 scopus 로고    scopus 로고
    • Current industrial practices of assessing permeability and P-glycoprotein interaction
    • Balimane P.V., Han Y.H., Chong S. Current industrial practices of assessing permeability and P-glycoprotein interaction. AAPS J. 2006, 8:E1-13.
    • (2006) AAPS J. , vol.8
    • Balimane, P.V.1    Han, Y.H.2    Chong, S.3
  • 6
    • 1642454475 scopus 로고    scopus 로고
    • ABC transporters and the blood-brain barrier
    • Begley D.J. ABC transporters and the blood-brain barrier. Curr. Pharm. Des. 2004, 10:1295-1312.
    • (2004) Curr. Pharm. Des. , vol.10 , pp. 1295-1312
    • Begley, D.J.1
  • 7
    • 0043092355 scopus 로고    scopus 로고
    • Do cell culture conditions influence the carrier-mediated transport of peptides in Caco-2 cell monolayers?
    • Behrens I., Kissel T. Do cell culture conditions influence the carrier-mediated transport of peptides in Caco-2 cell monolayers?. Eur. J. Pharm. Sci. 2003, 19:433-442.
    • (2003) Eur. J. Pharm. Sci. , vol.19 , pp. 433-442
    • Behrens, I.1    Kissel, T.2
  • 8
    • 33645028973 scopus 로고    scopus 로고
    • Simvastatin does not influence the intestinal P-glycoprotein and MPR2, and the disposition of talinolol after chronic medication in healthy subjects genotyped for the ABCB1, ABCC2 and SLCO1B1 polymorphisms
    • Bernsdorf A., Giessmann T., Modess C., Wegner D., Igelbrink S., Hecker U., Haenisch S., Cascorbi I., Terhaag B., Siegmund W. Simvastatin does not influence the intestinal P-glycoprotein and MPR2, and the disposition of talinolol after chronic medication in healthy subjects genotyped for the ABCB1, ABCC2 and SLCO1B1 polymorphisms. Br. J. Clin. Pharmacol. 2006, 61:440-450.
    • (2006) Br. J. Clin. Pharmacol. , vol.61 , pp. 440-450
    • Bernsdorf, A.1    Giessmann, T.2    Modess, C.3    Wegner, D.4    Igelbrink, S.5    Hecker, U.6    Haenisch, S.7    Cascorbi, I.8    Terhaag, B.9    Siegmund, W.10
  • 9
    • 0030909506 scopus 로고    scopus 로고
    • The influence of culture time and passage number on the morphological and physiological development of Caco-2 cells
    • Briske-Anderson M.J., Finley J.W., Newman S.M. The influence of culture time and passage number on the morphological and physiological development of Caco-2 cells. Proc. Soc. Exp. Biol. Med. 1997, 214:248-257.
    • (1997) Proc. Soc. Exp. Biol. Med. , vol.214 , pp. 248-257
    • Briske-Anderson, M.J.1    Finley, J.W.2    Newman, S.M.3
  • 10
    • 0346728729 scopus 로고    scopus 로고
    • The ABCs of drug transport in intestine and liver: efflux proteins limiting drug absorption and bioavailability
    • Chan L.M., Lowes S., Hirst B.H. The ABCs of drug transport in intestine and liver: efflux proteins limiting drug absorption and bioavailability. Eur. J. Pharm. Sci. 2004, 21:25-51.
    • (2004) Eur. J. Pharm. Sci. , vol.21 , pp. 25-51
    • Chan, L.M.1    Lowes, S.2    Hirst, B.H.3
  • 11
    • 58149164868 scopus 로고    scopus 로고
    • In vitro-in vivo correlation in P-glycoprotein mediated transport in intestinal absorption
    • del Amo E.M., Heikkinen A.T., Mönkkönen J. In vitro-in vivo correlation in P-glycoprotein mediated transport in intestinal absorption. Eur. J. Pharm. Sci. 2009, 36:200-211.
    • (2009) Eur. J. Pharm. Sci. , vol.36 , pp. 200-211
    • del Amo, E.M.1    Heikkinen, A.T.2    Mönkkönen, J.3
  • 12
    • 0031818952 scopus 로고    scopus 로고
    • Radioligand-binding assay employing P-glycoprotein-overexpressing cells: testing drug affinities to the secretory intestinal multidrug transporter
    • Döppenschmitt S., Spahn-Langguth H., Regårdh C.G., Langguth P. Radioligand-binding assay employing P-glycoprotein-overexpressing cells: testing drug affinities to the secretory intestinal multidrug transporter. Pharm. Res. 1998, 15:1001-1006.
    • (1998) Pharm. Res. , vol.15 , pp. 1001-1006
    • Döppenschmitt, S.1    Spahn-Langguth, H.2    Regårdh, C.G.3    Langguth, P.4
  • 14
    • 0032885452 scopus 로고    scopus 로고
    • Role of P-glycoprotein-mediated secretion in absorptive drug permeability: An approach using passive membrane permeability and affinity to P-glycoprotein
    • Döppenschmitt S., Spahn-Langguth H., Regårdh C.G., Langguth P. Role of P-glycoprotein-mediated secretion in absorptive drug permeability: An approach using passive membrane permeability and affinity to P-glycoprotein. J. Pharm. Sci. 1999, 88:1067-1072.
    • (1999) J. Pharm. Sci. , vol.88 , pp. 1067-1072
    • Döppenschmitt, S.1    Spahn-Langguth, H.2    Regårdh, C.G.3    Langguth, P.4
  • 15
    • 0033669380 scopus 로고    scopus 로고
    • Evaluation of a vincristine resistant Caco-2 cell line for use in a calcein AM extrusion screening assay for P-glycoprotein interaction
    • Eneroth A., Aström E., Hoogstraate J., Schrenk D., Conrad S., Kauffmann H.M., Gjellan K. Evaluation of a vincristine resistant Caco-2 cell line for use in a calcein AM extrusion screening assay for P-glycoprotein interaction. Eur. J. Pharm. Sci. 2001, 12:205-214.
    • (2001) Eur. J. Pharm. Sci. , vol.12 , pp. 205-214
    • Eneroth, A.1    Aström, E.2    Hoogstraate, J.3    Schrenk, D.4    Conrad, S.5    Kauffmann, H.M.6    Gjellan, K.7
  • 18
    • 0031780682 scopus 로고    scopus 로고
    • Correlation between oral drug absorption in humans, and apparent drug permeability in TC-7 cells, a human epithelial intestinal cell line: comparison with the parental Caco-2 cell line
    • Grès M.C., Julian B., Bourrié M., Meunier V., Roques C., Berger M., Boulenc X., Berger Y., Fabre G. Correlation between oral drug absorption in humans, and apparent drug permeability in TC-7 cells, a human epithelial intestinal cell line: comparison with the parental Caco-2 cell line. Pharm. Res. 1998, 15:726-733.
    • (1998) Pharm. Res. , vol.15 , pp. 726-733
    • Grès, M.C.1    Julian, B.2    Bourrié, M.3    Meunier, V.4    Roques, C.5    Berger, M.6    Boulenc, X.7    Berger, Y.8    Fabre, G.9
  • 19
    • 0036176510 scopus 로고    scopus 로고
    • Mechanisms of cancer drug resistance
    • Gottesman M.M. Mechanisms of cancer drug resistance. Annu. Rev. Med. 2002, 53:615-627.
    • (2002) Annu. Rev. Med. , vol.53 , pp. 615-627
    • Gottesman, M.M.1
  • 21
    • 0037331236 scopus 로고    scopus 로고
    • Isolation and characterization of Caco-2 subclones expressing high levels of multidrug resistance protein efflux transporter
    • Horie K., Tang F., Borchardt R.T. Isolation and characterization of Caco-2 subclones expressing high levels of multidrug resistance protein efflux transporter. Pharm. Res. 2003, 20:161-168.
    • (2003) Pharm. Res. , vol.20 , pp. 161-168
    • Horie, K.1    Tang, F.2    Borchardt, R.T.3
  • 22
    • 0027522919 scopus 로고
    • The development and characterization of Vinca alkaloid-resistant Caco-2 human colorectal cell lines expressing mdr-1
    • Hoskins J., DeHerdt S.V., Moore R.E., Bumol T.F. The development and characterization of Vinca alkaloid-resistant Caco-2 human colorectal cell lines expressing mdr-1. Int. J. Cancer 1993, 20:680-688.
    • (1993) Int. J. Cancer , vol.20 , pp. 680-688
    • Hoskins, J.1    DeHerdt, S.V.2    Moore, R.E.3    Bumol, T.F.4
  • 24
    • 38449084547 scopus 로고    scopus 로고
    • Determination of drug permeability and prediction of drug absorption in Caco-2 monolayers
    • Hubatsch I., Ragnarsson E.G., Artursson P. Determination of drug permeability and prediction of drug absorption in Caco-2 monolayers. Nat. Protoc. 2007, 2:2111-2119.
    • (2007) Nat. Protoc. , vol.2 , pp. 2111-2119
    • Hubatsch, I.1    Ragnarsson, E.G.2    Artursson, P.3
  • 29
    • 0031925268 scopus 로고    scopus 로고
    • Human intestinal permeability
    • Lennernäs H. Human intestinal permeability. J. Pharm. Sci. 1998, 87:403-410.
    • (1998) J. Pharm. Sci. , vol.87 , pp. 403-410
    • Lennernäs, H.1
  • 30
    • 0034467860 scopus 로고    scopus 로고
    • Influence of passive permeability on apparent P-glycoprotein kinetics
    • Lentz K.A., Polli J.W., Wring S.A., Humphreys J.E., Polli J.E. Influence of passive permeability on apparent P-glycoprotein kinetics. Pharm. Res. 2000, 17:1456-1460.
    • (2000) Pharm. Res. , vol.17 , pp. 1456-1460
    • Lentz, K.A.1    Polli, J.W.2    Wring, S.A.3    Humphreys, J.E.4    Polli, J.E.5
  • 31
    • 0037457793 scopus 로고    scopus 로고
    • Drug-drug interaction mediated by inhibition and induction of P-glycoprotein
    • Lin J.H. Drug-drug interaction mediated by inhibition and induction of P-glycoprotein. Adv. Drug Deliv. Rev. 2003, 55:53-81.
    • (2003) Adv. Drug Deliv. Rev. , vol.55 , pp. 53-81
    • Lin, J.H.1
  • 32
    • 1442301563 scopus 로고    scopus 로고
    • How significant is the role of P-glycoprotein in drug absorption and brain uptake?
    • Lin J.H. How significant is the role of P-glycoprotein in drug absorption and brain uptake?. Drugs Today 2004, 40:5-22.
    • (2004) Drugs Today , vol.40 , pp. 5-22
    • Lin, J.H.1
  • 34
    • 1842737790 scopus 로고    scopus 로고
    • Tacrolimus therapy according to mucosal MDR1 levels in small-bowel transplant recipients
    • Masuda S., Uemoto S., Goto M., Fujimoto Y., Tanaka K., Inui K. Tacrolimus therapy according to mucosal MDR1 levels in small-bowel transplant recipients. Clin. Pharmacol. Ther. 2004, 75:352-361.
    • (2004) Clin. Pharmacol. Ther. , vol.75 , pp. 352-361
    • Masuda, S.1    Uemoto, S.2    Goto, M.3    Fujimoto, Y.4    Tanaka, K.5    Inui, K.6
  • 35
    • 3242728359 scopus 로고    scopus 로고
    • Levothyroxine up-regulates P-glycoprotein independent of the pregnane×receptor
    • Mitin T., Von Moltke L.L., Court M.H., Greenblatt D.J. Levothyroxine up-regulates P-glycoprotein independent of the pregnane×receptor. Drug Metab. Dispos. 2004, 32:779-782.
    • (2004) Drug Metab. Dispos. , vol.32 , pp. 779-782
    • Mitin, T.1    Von Moltke, L.L.2    Court, M.H.3    Greenblatt, D.J.4
  • 36
    • 0042468096 scopus 로고    scopus 로고
    • Impact of drug transporter studies on drug discovery and development
    • Mizuno N., Niwa T., Yotsumoto Y., Sugiyama Y. Impact of drug transporter studies on drug discovery and development. Pharmacol. Rev. 2003, 55:425-461.
    • (2003) Pharmacol. Rev. , vol.55 , pp. 425-461
    • Mizuno, N.1    Niwa, T.2    Yotsumoto, Y.3    Sugiyama, Y.4
  • 38
    • 0043127396 scopus 로고    scopus 로고
    • PH-dependent bidirectional transport of weakly basic drugs across Caco-2 monolayers: implications for drug-drug interactions
    • Neuhoff S., Ungell A.L., Zamora I., Artursson P. pH-dependent bidirectional transport of weakly basic drugs across Caco-2 monolayers: implications for drug-drug interactions. Pharm. Res. 2003, 20:1141-1148.
    • (2003) Pharm. Res. , vol.20 , pp. 1141-1148
    • Neuhoff, S.1    Ungell, A.L.2    Zamora, I.3    Artursson, P.4
  • 41
    • 0028825399 scopus 로고
    • Absence of the mdr1a P-glycoprotein in mice affects tissue distribution and pharmacokinetics of dexamethasone, digoxin and cyclosporin A
    • Schinkel A.H., Wagenaar E., van Deemter L., Mol C.A., Borst P. Absence of the mdr1a P-glycoprotein in mice affects tissue distribution and pharmacokinetics of dexamethasone, digoxin and cyclosporin A. J. Clin. Investig. 1995, 96:1698-1705.
    • (1995) J. Clin. Investig. , vol.96 , pp. 1698-1705
    • Schinkel, A.H.1    Wagenaar, E.2    van Deemter, L.3    Mol, C.A.4    Borst, P.5
  • 42
    • 0029892497 scopus 로고    scopus 로고
    • P-glycoprotein in the blood-brain barrier of mice influences the brain penetration and pharmacological activity of many drugs
    • Schinkel A.H., Wagenaar E., Mol C.A., van Deemter L. P-glycoprotein in the blood-brain barrier of mice influences the brain penetration and pharmacological activity of many drugs. J. Clin. Investig. 1996, 97:2517-2524.
    • (1996) J. Clin. Investig. , vol.97 , pp. 2517-2524
    • Schinkel, A.H.1    Wagenaar, E.2    Mol, C.A.3    van Deemter, L.4
  • 43
    • 0037464458 scopus 로고    scopus 로고
    • Comparison of in vitro P-glycoprotein screening assays: recommendations for their use in drug discovery
    • Schwab D., Fischer H., Tabatabaei A., Poli S., Huwyler J. Comparison of in vitro P-glycoprotein screening assays: recommendations for their use in drug discovery. J. Med. Chem. 2003, 46:1716-1725.
    • (2003) J. Med. Chem. , vol.46 , pp. 1716-1725
    • Schwab, D.1    Fischer, H.2    Tabatabaei, A.3    Poli, S.4    Huwyler, J.5
  • 45
    • 38349174530 scopus 로고    scopus 로고
    • Effect of P-glycoprotein expression levels on the concentration-dependent permeability of drugs to the cell membrane
    • Shirasaka Y., Sakane T., Yamashita S. Effect of P-glycoprotein expression levels on the concentration-dependent permeability of drugs to the cell membrane. J. Pharm. Sci. 2008, 97:553-565.
    • (2008) J. Pharm. Sci. , vol.97 , pp. 553-565
    • Shirasaka, Y.1    Sakane, T.2    Yamashita, S.3
  • 47
    • 77953303004 scopus 로고    scopus 로고
    • Towards prediction of in vivo intestinal absorption using a 96-well Caco-2 assay
    • Skolnik S., Lin X., Wang J., Chen X.H., He T., Zhang B. Towards prediction of in vivo intestinal absorption using a 96-well Caco-2 assay. J. Pharm. Sci. 2010, 99:3246-3265.
    • (2010) J. Pharm. Sci. , vol.99 , pp. 3246-3265
    • Skolnik, S.1    Lin, X.2    Wang, J.3    Chen, X.H.4    He, T.5    Zhang, B.6
  • 49
    • 0033739725 scopus 로고    scopus 로고
    • Role of metabolic enzymes and efflux transporters in the absorption of drugs from the small intestine
    • Suzuki H., Sugiyama Y. Role of metabolic enzymes and efflux transporters in the absorption of drugs from the small intestine. Eur. J. Pharm. Sci. 2000, 12:3-12.
    • (2000) Eur. J. Pharm. Sci. , vol.12 , pp. 3-12
    • Suzuki, H.1    Sugiyama, Y.2
  • 51
    • 0041402720 scopus 로고    scopus 로고
    • Efflux ratio cannot assess P-glycoprotein-mediated attenuation of absorptive transport: asymmetric effect of P-glycoprotein on absorptive and secretory transport across Caco-2 cell monolayers
    • Troutman M.D., Thakker D.R. Efflux ratio cannot assess P-glycoprotein-mediated attenuation of absorptive transport: asymmetric effect of P-glycoprotein on absorptive and secretory transport across Caco-2 cell monolayers. Pharm. Res. 2003, 20:1200-1209.
    • (2003) Pharm. Res. , vol.20 , pp. 1200-1209
    • Troutman, M.D.1    Thakker, D.R.2
  • 54
    • 39749114622 scopus 로고    scopus 로고
    • Variability in Caco-2 and MDCK cell-based intestinal permeability assays
    • Volpe D.A. Variability in Caco-2 and MDCK cell-based intestinal permeability assays. J. Pharm. Sci. 2008, 97:712-725.
    • (2008) J. Pharm. Sci. , vol.97 , pp. 712-725
    • Volpe, D.A.1
  • 55
    • 0029142558 scopus 로고
    • Heterogeneity in the human intestinal cell line Caco-2 leads to differences in the transepithelial transport
    • Walter E., Kissel T. Heterogeneity in the human intestinal cell line Caco-2 leads to differences in the transepithelial transport. Eur. J. Pharm. Sci. 1995, 3:215-230.
    • (1995) Eur. J. Pharm. Sci. , vol.3 , pp. 215-230
    • Walter, E.1    Kissel, T.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.